References and Notes
1a
Handratta VD.
Vasaitis TS.
Njar VCO.
Gediya LK.
Kataria R.
Chopra P.
Newman D.
Farquhar R.
Guo Z.
Qiu Y.
Brodie AMH.
J. Med. Chem.
2005,
48:
2972
1b
Gohlke H.
Gundisch D.
Schwarz S.
Seitz G.
Tilotta MC.
Wegge T.
J. Med. Chem.
2002,
45:
1064
2a
Levitzki A.
Acc. Chem. Res.
2003,
36:
462
2b
Manegold C.
EJC Supplements
2004,
2:
34
3
Skaper SD.
Kee WJ.
Facci L.
McDonald G.
Doherty P.
Walsh FS.
J. Neurochem.
2000,
75:
1520
4
Audoux J.
Plé N.
Turck A.
Queguiner G.
Tetrahedron
2004,
60:
6353
5
Hamby JM.
Showalter HDH.
Pharmacol. Ther.
1999,
82:
169
6
Natarajan SR.
Wisnoski DD.
Singh SB.
Stelmach JE.
O’Neill EA.
Schwartz CD.
Thompson CM.
Fitzgerald CE.
O’Keefe SJ.
Kumar S.
Hop CECA.
Zaller DM.
Schmatz DM.
Doherty JB.
Bioorg. Med. Chem. Lett.
2003,
13:
273
7
Audoux J.
Plé N.
Turck A.
Queguiner G.
Tetrahedron
2004,
60:
4107
8
Robins RK.
Hitchings GH.
J. Am. Chem. Soc.
1956,
78:
973
9
Mamouni R.
Akssira M.
Aadil M.
Elhakmaoui A.
Lasri J.
Zabellos-Garcia E.
Synth. Commun.
2003,
33:
4259
10
Mamouni R.
Aadil M.
Akssira M.
Lasri J.
Sepulveda-Arques J.
Tetrahedron Lett.
2003,
44:
2745
11
Kenyon J.
Thaker K.
J. Chem. Soc.
1957,
2531
12
Synthesis of 4.
A solution containing the 2,3-pyridine-carboxylic acid 2-methylester (2, 5 g, 27.62 mmol) and Et3N (5.05 mL, 1.3 equiv, 35.90 mmol) in dry THF (100 mL) was cooled at
-10 °C. Ethyl chloroformate (3.96 ml, 1.5 equiv, 41.33 mmol) was added dropwise and the reaction mixture was stirred at this temperature for 1.5 h. A solution of NaN3 (3.05 g, 1.7 equiv, 46.95 mmol) in H2O (35 mL) was then added in one portion. After 1.5 h at 0 °C, the resulting heterogeous mixture was filtered, the organic solvent was removed under reduced pressure and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO4, and concentrated in vacuo. The crude acyl azide was next dissolved in toluene (30 mL) and the solution was refluxed for 2 h. After cooling to r.t., a solution of 4-methoxybenzylamine (3.6 mL, 1 equiv, 27.62 mmol) in pyridine (30 mL) was added and the reaction mixture was refluxed for 24 h. The dark red solution was else evaporated to dryness and the residue was washed with EtOH (2 × 50 mL) and filtered to obtain compound 4 as a white solid (71% yield); mp 328-330 °C. IR (KBr): 3368, 3059, 2853, 1710, 1672, 1401, 1247, 809, 691 cm -1. 1H NMR (250 MHz, DMSO-d
6): δ = 3.70 (s, 3 H, OCH3), 5.02 (s, 2 H, CH2), 6.86 (d, 2 H, J = 8.5 Hz, HAr), 7.30 (d, 2 H, J = 8.5 Hz, HAr), 7.57-7.67 (m, 2 H, HPy), 8.49 (dd, 1 H, J = 1.6, 4.1 Hz, H6), 11.57 (s, 1 H, NH, exchangeable D2O) ppm. 13C NMR (62.5 MHz, DMSO-d
6) δ = 42.7 (CH2), 54.7 (CH3), 113.4 (2 CH), 123.4 (CH), 128.6 (CH), 128.9 (Cq), 129.0 (2 CH), 130.5 (Cq), 136.5 (Cq), 144.8 (CH), 149.4 (Cq), 158.1 (CO), 160.2 (CO) ppm. HRMS (EI-MS): m/z calcd for C15H13N3O3: 283.0956; found: 283.0967.
13a
Miki Y.
Hachiken H.
Kashima Y.
Sugimura W.
Yanase N.
Heterocycles
1998,
48:
1
13b
Joseph B.
Behard A.
Lesur B.
Guillaumet G.
Synlett
2003,
1542
14
Akiyama T.
Kumegawa M.
Takesue Y.
Nishimoto H.
Ozaki S.
Chem. Lett.
1990,
3:
339
15
Preparation of 6.
A mixture of 1H,3H-pyrido[3,2-d]pyrimidine-2,4-dione (5, 1 g, 5 mmol), POCl3 (10 mL) and PCl5 (5.41 g, 4 equiv) was refluxed for 4 h then cooled to r.t. Excess POCl3 was evaporated and the residue neutralized with aq Na2CO3 and extracted with CH2Cl2. The combined organic layers were dried over MgSO4, and concentrated in vacuo. The residue was purified by flash chromatography (PE-EtOAc, 8:2) to afford compound 6 as a pale yellow solid (58% yield); mp 168-169 °C. IR (KBr): 3068, 1537, 1462, 1443, 1369, 1186, 1107, 878, 831, 794 cm-1. 1H NMR (250 MHz, CDCl3): d = 7.92 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8,33 (dd, 1 H, J = 1.6, 8.5 Hz, H8), 9.14 (dd, 1 H, J = 1.6, 4.1 Hz, H6) ppm. 13C NMR (62.5 MHz, CDCl3): d = 130.3 (CH), 136.3 (CH), 137.1 (Cq), 149.0 (Cq), 153.2 (CH), 155.8 (Cq), 166.2 (Cq) ppm. HRMS (EI-MS): m/z calcd for C7H3
35Cl2N3: 198.9704; found: 198.9715.
16
Lavecchia G.
Berteina-Raboin S.
Guillaumet G.
Tetrahedron Lett.
2005,
46:
5851
17
Gupta M.
Nair V.
Tetrahedron Lett.
2005,
46:
1165
18
Chen YL.
Hung HM.
Lu CM.
Li KC.
Tzeng CC.
Bioorg. Med. Chem.
2004,
12:
6539
19
Ding Y.
An H.
Hong Z.
Girardet JL.
Bioorg. Med. Chem. Lett.
2005,
15:
725
20
Zeng Q.
Huang B.
Danielsen K.
Shukla R.
Nagy T.
Org. Process. Res. Dev.
2004,
8:
962
21a
Huddleston NE.
Harris JL.
Nguyen HL.
Ray PS.
Heterocycl. Commun.
2004,
10:
405
21b
Huddleston NE.
Harris JL.
Nguyen HL.
Ray PS.
Heterocycl. Commun.
2004,
10:
7533
22
Wéber C.
Demeter A.
Szendrei GI.
Greiner I.
Tetrahedron Lett.
2003,
44:
7533
23
Preparation of 9.
A solution containing the 2,4-dichloropyrido[3,2-d]pyrimi-dine (6, 500 mg, 2.5 mmol) in dry THF (25 mL) was cooled at 0 °C. Then, a prebuilt suspension of 2-propanethiol (0.232 mL, 1 equiv) and NaH (105 mg, 60% in oil, 1.05 equiv) in dry THF (15 mL) was dropwise added. The reaction mixture was allowed to r.t. and stirred overnight. Hydrolysis was realized with cold H2O (30 mL) and the aqueous layers were extracted with EtOAc (3 × 20 mL). The combined organic layers were dried on MgSO4, filtered and evaporated under reduced pressure. The crude residue was purified by silica gel column chromatography (PE-EtOAc, 8:2) to afford compound 9 (88% yield); mp 93-94 °C. IR (KBr): 2963, 1555, 1518, 1458, 1426, 1334, 1169, 1110, 876, 853, 821, 720 cm-1. 1H NMR (250 MHz, CDCl3): δ = 1.48 (d, 6 H, J = 6.9 Hz, 2 CH3), 4.18 (m, 1 H, J = 6.9 Hz, CH), 7.73 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.11 (dd, 1 H, J = 1.6, 8.5 Hz, H8), 8.84 (dd, 1 H, J = 1.6, 4.1 Hz, H6) ppm. 13C NMR ( 62.5 MHz, CDCl3): δ = 22.6 (2 CH3), 35.3 (CH), 129.1 (CH), 135.9 (CH), 137.9 (Cq), 145.1 (Cq), 150.3 (CH), 156.5 (Cq), 178.1 (Cq) ppm. HRMS (EI-MS): m/z calcd for C10H10
35ClN3S: 239.02840; found: 239.0273.
24 Diffraction data were collected using a CAD4 Enraf-Nonius. Full crystallographic results have been deposited as Supplementary Materials at the Cambridge Crystallographic Data Centre, University Chemical Lab, 12 Union Road, Cambridge CB2 1EZ UK; e-mail: deposit@ccdc.cam.ac.uk.
25
Preparation of 21.
To a solution of 2-chloro-4-isopropylsulfanylpyrido[3,2-d]pyrimidine (9, 100 mg, 0.42 mmol) in DME (6 mL) were successively added 4-methoxyphenylboronic acid (76 mg, 1.2 equiv) and a solution of Na2CO3 (89 mg, 2 equiv) in H2O (3 mL) and Pd(PPh3)4 (24 mg, 0.05 equiv). The reaction mixture was heated at 75 °C under vigorous stirring under argon atmosphere. After complete disappearance of 9, the solution was concentrated in vacuo and the residue diluted in H2O (10 mL). After extraction with CH2Cl2 (3 × 20 mL), the dried organic layers were evaporated to dryness. The crude material was purified by flash column chromatography (PE-CH2Cl2, 3:7) to afford compound 21 as a white solid (85% yield); mp 125-126 °C. IR (KBr): 2954, 1600, 1587, 1536, 1458, 1435, 1376, 1165, 839, 821, 747, 696 cm-1. 1H NMR (250 MHz, CDCl3): δ = 1.58 (d, 6 H, J = 6.9 Hz, 2 CH3), 3.86 (s, 3 H, OCH3), 4.33 (m, 1 H, J = 6.9 Hz, CH), 7,00 (d, 2 H, J = 8.8 Hz, H3
′), 7.65 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.17 (dd, 1 H, J = 1.0, 8.5 Hz, H8), 8.53 (d, 2 H, J = 8.8 Hz, H2
′), 8.78 (dd, 1 H, J = 1.0, 4.1 Hz, H6) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 22.7 (2 CH3), 34.6 (CH), 55.4 (CH3), 113.9 (CH), 128.3 (CH), 130.2 (Cq), 130.5 (CH), 136.6 (CH), 138.0 (Cq), 144.4 (Cq), 149.0 (CH), 159.5 (Cq), 162.1 (Cq), 173.8 (Cq). HRMS (EI-MS): m/z calcd for C17H17N3OS: 311.10923; found: 311.1116.
26
Aboul-Fadl T.
Löber S.
Gmeiner P.
Synthesis
2000,
1727
27
Synthesis of 25.
A solution of 2,4-dichloropyrido[3,2-d]pyrimidine (6, 1.0 g, 5 mmol), Bu3SnH (1.48 mL, 1.1 equiv, 5.5 mmol) in toluene (60 mL) was degassed by argon bubbling during 30 min. Then, Pd(PPh3)4 (290 mg, 0.05 equiv, 0.25 mmol) was added in one portion and the reaction mixture was placed in a pre-heated oil 100 °C for 1 h. After cooling to r.t., the solvent was evaporated in vacuo and a sat. solution of KF (20 mL) was added. After filtration, the aqueous layers were extracted with EtOAc (3 × 25 mL). The combined organic layers were dried over MgSO4, and concentrated in vacuo. The crude material was purified by flash chromatography (PE-EtOAc, 8:2) to afford compound 25 as a white solid (86% yield); mp 119-120 °C. IR (KBr): 3059, 1560, 1462, 1439, 1359, 1154, 1098, 873, 822, 696 cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.89 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.32 (d, 1 H, J = 8.5 Hz, H8), 9.11 (dd, 1 H, J = 1.6, 4.1 Hz, H6), 9.54 (s, 1 H, H4) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 129.5 (CH, C7), 135.6 (CH, C8), 139.2 (Cq, C4a), 148.6 (Cq, C8a), 153.0 (CH, C6), 158.0 (Cq, C2), 164.6 (CH, C4) ppm. HRMS (EI-MS): m/z calcd for C7H4N3
35Cl: 165.00937; found: 165.0104.